ROSARIO, Argentina & DAVIS, Calif.–(BUSINESS WIRE)–Verdeca, a joint venture between Bioceres Crop Solutions Corp. (NYSE American: BIOX) and Arcadia Biosciences, Inc. (Nasdaq: RKDA), announced today it has successfully completed the regulatory review process and received approval for its HB4® drought and herbicide tolerant soybeans from the Paraguayan Minister of Agriculture, through the National Commission for…
DetailsHENDERSON, Nev.–(BUSINESS WIRE)–EVIO Inc. (the “Company” or “EVIO”) (OTCQB:EVIO) is pleased to announce that EVIO Labs Portland and EVIO Labs Medford recently expanded their lab capabilities and services to further meet the needs of the State of Oregon’s evolving, yet expanding, Cannabis and Hemp markets. EVIO Labs Portland has been granted accreditation to perform pesticide…
DetailsNEW YORK–(BUSINESS WIRE)–FreshDirect, the Northeast’s leading online fresh food grocer, today announced its top food trends for 2020. The trends list was curated by FreshDirect’s in-house team of food and wine specialists. “By working directly with farmers, fishermen, artisans and producers daily to source high-quality, great tasting food for our customers, FreshDirect has a unique…
DetailsMONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, provided a corporate update today and announced details for its fiscal fourth quarter ended August 31, 2019 (“Q4 2019”) and full year 2019 conference call. The Company is scheduled…
DetailsCHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, will report its financial results for the third quarter ended September 30, 2019, on Tuesday, November 26, 2019 after the market closes. The Company will hold a conference call and webcast to discuss…
DetailsUTICA, N.Y.–(BUSINESS WIRE)–CONMED Corporation (NASDAQ: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Jefferies London Healthcare Conference at 9:20 a.m. GMT (4:20 a.m. ET) on Wednesday, November 20, 2019 in London, UK. A live webcast of the presentation will be accessible through the “Investors” section…
DetailsSALT LAKE CITY–(BUSINESS WIRE)–As the outbreak of lung injuries and deaths associated with e-cigarettes, or vaping, continues to spread across the U.S., researchers at Intermountain Healthcare in Salt Lake City have effectively developed a best practice guide to quickly identify and treat patients who develop the new and potentially fatal respiratory injury, according to a…
DetailsWILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including: Credit Suisse 28th Annual Healthcare Conference in Scottsdale, Arizona on Tuesday, November 12th, at 10:20 a.m. MST (8:20 a.m. EST); Jefferies 2019 London Healthcare Conference in London, England on Thursday, November 21st, at 9:20…
DetailsSANTA CLARA, Calif.–(BUSINESS WIRE)–Golden Impressions Marketing, Inc. today announces it is expanding its operation from Denver to Silicon Valley to better serve local clients and be close to rapidly expanding markets. Additionally, Golden Impressions (GI) is announcing the expansion of its management team and the publishing of its new website. Proximity to Silicon Valley Silicon…
DetailsDUBLIN–(BUSINESS WIRE)–The “United States Legal Marijuana Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering. The country research report on United States legal marijuana market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts,…
DetailsCAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, presented a novel approach to producing human induced pluripotent stem cell (iPSC)-derived organoids at scale in an oral presentation on November 9th at the American Society of Nephrology (ASN) Kidney Week 2019…
DetailsCHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD.PR.A), a nationally recognized consumer cannabidiol (CBD) brand, announced today preliminary unaudited net sales for the fourth quarter of fiscal 2019 which ended September 30, 2019. “cbdMD’s unaudited net sales were $9.5 million for our last quarter of fiscal 2019, which was an increase of over…
Details